AMZN
Amazon.com, Inc.
AMZN has the edge over HEPS overall, supported by stronger valuation and stronger fundamentals.
HEPS
D-Market Elektronik Hizmetler ve Ticaret A.S.
HEPS trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
HEPS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
HEPS's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
HEPS PE Valuation
HEPS has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
HEPS Forward outlook
There aren't enough analyst estimates for HEPS to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over HEPS on earnings quality, reporting a profit while its opponent remains loss making.
HEPS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.44 | -$0.31 |
| Q1 2026 | -$0.39 | -$0.28 |
| Q4 2025 | -$0.35 | -$0.26 |
| Q3 2025 | -$0.19 | -$0.10 |
| Q2 2025 | -$0.13 | -$0.05 |
| Q1 2025 | -$0.11 | -$0.10 |
| Q4 2024 | -$0.09 | -$0.06 |
| Q3 2024 | -$0.09 | -$0.08 |
HEPS lost $0.44 per share over the past year, and its loss has widened in each of the last six quarters.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over HEPS on profitability, with a higher operating margin.
HEPS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $453.9M | +36% |
| Q1 2026 | $460.4M | +61% |
| Q4 2025 | $603.7M | +48% |
| Q3 2025 | $396.4M | +63% |
| Q2 2025 | $333.2M | +23% |
| Q1 2025 | $286.3M | -7.9% |
| Q4 2024 | $406.7M | +46% |
| Q3 2024 | $243.6M | +1.7% |
HEPS's revenue has grown year over year for five quarters in a row: $454M last quarter, up 36% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.9% | -3.1 points |
| Q1 2026 | -1.9% | +1.9 points |
| Q4 2025 | 0.9% | +0.3 points |
| Q3 2025 | -3% | -3.2 points |
| Q2 2025 | 0.2% | +0.5 points |
| Q1 2025 | -3.8% | -2.9 points |
| Q4 2024 | 0.7% | +2.6 points |
| Q3 2024 | 0.3% | +2.3 points |
HEPS's operating margin was −2.9% last quarter, down 3.1 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
HEPS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $29.3M | -56% |
| Q1 2026 | -$61.5M | -$60.6M |
| Q4 2025 | $14.9M | +$15.4M |
| Q3 2025 | $438.9K | +30% |
| Q2 2025 | $66.5M | +$67.4M |
| Q1 2025 | -$928.4K | -510% |
| Q4 2024 | -$582.5K | -133% |
| Q3 2024 | $337.1K | -66% |
HEPS has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over HEPS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
HEPS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +3.1M shares |
| 1 year | +15% | +47.7M shares |
| 3 years | +14% | +44.2M shares |
| 5 years | +14% | +44.5M shares |
| Available history | +14% | +44.5M shares |
HEPS has 371M diluted shares, up 15% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HEPS hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HEPS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.3x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -6.3x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
HEPS has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
HEPS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.7 | Neutral |
| Stochastic | 60.1 | Neutral |
HEPS's weekly RSI is 50 (neutral) and its Stochastic is 60 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
HEPS PE vs Consumer Cyclical Sector
| Metric | HEPS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HEPS has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over HEPS on trend strength, trading above more of its moving averages.
HEPS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.68 | 1.1% above |
| 20 week MA | $2.73 | 0.7% below |
| 50 week MA | $2.73 | 0.7% below |
| 100 week MA | $2.79 | 2.9% below |
| 200 week MA | $2.28 | 19% above |
HEPS's trend is mixed: it's above two of its five weekly moving averages, and 19% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over HEPS on returns for 2026, with the stronger performance.
HEPS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $14.1 | $2.05 | -85% |
| 2022 | $2.05 | $0.69 | -66% |
| 2023 | $0.69 | $1.80 | +161% |
| 2024 | $1.80 | $3.26 | +81% |
| 2025 | $3.26 | $2.52 | -23% |
| 2026 YTD | $2.52 | $2.71 | +7.5% |
HEPS's yearly returns have swung widely, from +161% in 2023 to −85% in 2021. It's up 7.5% so far in 2026.